Understanding Greenhouse Growers’ Willingness to Use Municipal Recycled Water on Food Crops: The Need for Tailored Outreach Coupled with Deep Engagement to Increase Adoption

Increasing demand on agricultural water resources have caused a greater need for the use of municipal recycled wastewater (MRW) globally. However, in the United States, greenhouse growers have been slow to use it in their greenhouse operations. In this study, we seek to understand the factors that motivate and limit use of MRW among US growers. Using national survey data from 2019 through 2020, we developed a logistic regression model to understand the many factors influencing growers’ willingness to use MRW on food crops. We find that MRW quality is a primary concern and that growers’ willingness to use MRW is shaped by their direct and indirect knowledge of MRW, garnered from their own and others’ experiences using it. Given these findings, improving adoption of MRW requires collective experiential learning opportunities that gather target audiences with educators, policymakers, end users, and local authorities to simultaneously provide hands-on experience tailored to growers’ particular knowledge and concerns with feedback from peers

Preferential heating of light ions during an ionospheric Ar(+) injection experiment

The Argon Release for Controlled Studies (ARCS) 4 sounding rocket was launched northward into high altitude from Poker Flat Research Range on February 23, 1990. The vehicle crossed geomagnetic field lines containing discrete auroral activity. An instrumented subpayload released 100-eV and 200-eV Ar(+) ion beams sequentially, in a direction largely perpendicular to both the local geomagnetic field and the subpayload spin axis. The instrumented main payload was separated along field lines from the beam emitting subpayload by a distance which increased at a steady rate of approximately 2.4 m/s. Three dimensional mass spectrometric ion observations of ambient H(+) and O(+) ions, obtained on board the main payload, are presented. Main payload electric field observations in the frequency range 0-16 kHz, are also presented. These observations are presented to demonstrate the operation of transverse ion acceleration, which was differential with respect to ion mass, primarily during 100-eV beam operations. The preferential transverse acceleration of ambient H(+) ions, as compared with ambient O(+) ions, during the second, third, fourth, and fifth 100-eV beam operations, is attributed to a resonance among the injected Ar(+) ions, beam-generated lower hybrid waves, and H(+) ions in the tail of the ambient thermal distribution. This work provides experimental support of processes predicted by previously published theory and simulations

Anti-Nirvana: crime, culture and instrumentalism in the age of insecurity

‘Anti-Nirvana’ explores the relationship between consumer culture, media and criminal motivations. It has appeared consistently on the list of the top-ten most-read articles in this award-winning international journal, and it mounts a serious neo-Freudian challenge to the predominant naturalistic notion of ‘resistance’ at the heart of liberal criminology and media studies. It is also cited in the Oxford Handbook of Criminology and other criminology texts as a persuasive argument in support of the theory that criminality amongst young people is strongly linked to the acquisitive values of consumerism and the images of possessive individualism that dominate mass media

Generalized pricing formulas for stochastic volatility jump diffusion models applied to the exponential Vasicek model

Path integral techniques for the pricing of financial options are mostly based on models that can be recast in terms of a Fokker-Planck differential equation and that, consequently, neglect jumps and only describe drift and diffusion. We present a method to adapt formulas for both the path-integral propagators and the option prices themselves, so that jump processes are taken into account in conjunction with the usual drift and diffusion terms. In particular, we focus on stochastic volatility models, such as the exponential Vasicek model, and extend the pricing formulas and propagator of this model to incorporate jump diffusion with a given jump size distribution. This model is of importance to include non-Gaussian fluctuations beyond the Black-Scholes model, and moreover yields a lognormal distribution of the volatilities, in agreement with results from superstatistical analysis. The results obtained in the present formalism are checked with Monte Carlo simulations.Comment: 9 pages, 2 figures, 1 tabl

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.

BACKGROUND: Patients with advanced melanoma have limited treatment options after progression on immune checkpoint inhibitors (ICI). Lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, demonstrated an investigator-assessed objective response rate (ORR) of 36% in 66 patients who progressed after ICI and targeted therapy. Herein, we report independent review committee (IRC)-assessed outcomes of 153 patients treated with lifileucel in a large multicenter Phase 2 cell therapy trial in melanoma. METHODS: Eligible patients had advanced melanoma that progressed after ICI and targeted therapy, where appropriate. Melanoma lesions were resected (resected tumor diameter ≥1.5 cm) and shipped to a central good manufacturing practice facility for 22-day lifileucel manufacturing. Patients received a non-myeloablative lymphodepletion regimen, a single lifileucel infusion, and up to six doses of high-dose interleukin-2. The primary endpoint was IRC-assessed ORR (Response Evaluation Criteria in Solid Tumors V.1.1). RESULTS: The Full Analysis Set consisted of 153 patients treated with lifileucel, including longer-term follow-up on the 66 patients previously reported. Patients had received a median of 3.0 lines of prior therapy (81.7% received both anti-programmed cell death protein 1 and anti-cytotoxic lymphocyte-associated protein 4) and had high disease burden at baseline (median target lesion sum of diameters (SOD): 97.8 mm; lactate dehydrogenase (LDH) >upper limit of normal: 54.2%). ORR was 31.4% (95% CI: 24.1% to 39.4%), with 8 complete responses and 40 partial responses. Median duration of response was not reached at a median study follow-up of 27.6 months, with 41.7% of the responses maintained for ≥18 months. Median overall survival and progression-free survival were 13.9 and 4.1 months, respectively. Multivariable analyses adjusted for Eastern Cooperative Oncology Group performance status demonstrated that elevated LDH and target lesion SOD >median were independently correlated with ORR (p=0.008); patients with normal LDH and SOD <median had greater likelihood of response than those with either (OR=2.08) or both (OR=4.42) risk factors. The most common grade 3/4 treatment-emergent adverse events (≥30%) were thrombocytopenia (76.9%), anemia (50.0%), and febrile neutropenia (41.7%). CONCLUSIONS: Investigational lifileucel demonstrated clinically meaningful activity in heavily pretreated patients with advanced melanoma and high tumor burden. Durable responses and a favorable safety profile support the potential benefit of one-time lifileucel TIL cell therapy in patients with limited treatment options in ICI-refractory disease